U.S. Markets close in 3 hrs 53 mins

An Update on MDT’s Restorative Therapies after Fiscal Q1 2019

Daniel Collins
An Update on MDT’s Restorative Therapies after Fiscal Q1 2019

Medtronic’s (MDT) Restorative Therapies Group reported revenue of $1.9 billion in the fiscal first quarter of 2019 compared to $1.8 billion in the fiscal first quarter of 2018, reflecting ~8% YoY (year-over-year) growth. In the quarter, in US, non-US developed, and emerging markets, Medtronic’s Restorative Therapies Group reported revenues of $1.3 billion, $428.0 million, and $227.0 million, respectively, compared to $1.2 billion, $394.0 million, and $194.0 million, respectively, in the fiscal first quarter of 2018, reflecting YoY rises of ~6%, ~9%, and ~17%, respectively. In the quarter, Medtronic’s Spine segment generated revenue of $652.0 million compared to $649.0 million in the fiscal first quarter of 2018. In the US market, the segment reported revenue of $444.0 million, reflecting a ~2% YoY fall.